Harvard Bioscience Inc.

NASDAQ:HBIO  
3.74
-0.01 (-0.27%)
Earnings Announcements

Harvard Bioscience Announces First Quarter 2022 Financial Results

Published: 05/04/2022 13:35 GMT
Harvard Bioscience Inc. (HBIO) - Harvard Bioscience Announces First Quarter 2022 Financial Results.
Qtrly Revenues $28.8 Million Versus $27.0 Million.
Qtrly Loss per Share (GAAP) $0.17.
Q1 Diluted Adjusted Earnings per Share $0.04.
Q1 Earnings per Share View $0.05, Revenue View $28.8 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $30.49 Million
Adjusted EPS is expected to be $0.06

Next Quarter Revenue Guidance is expected to be $33.54 Million
Next Quarter EPS Guidance is expected to be $0.08

More details on our Analysts Page.